Talia Puzantian, PharmD, BCPP

Risks in Older Adults

Insomnia and Sleep Medications

April 1, 2025

Talia Puzantian, PharmD, BCPP and Shireen Wissa, PharmD

Shireen Wissa, PharmD candidate and Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Examining the long-term impacts of common sleep aids in older adults should urge a rethinking of prescribing practices.

News of Note

News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment

October 1, 2024

Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP

Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.

Clinical Update

Considerations in Prescribing Lithium in Older Adults

October 1, 2024

Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP

Shireen Wissa, PharmD Candidate 2025. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.

Risks in Older Adults

Antidepressants and Hyponatremia

April 1, 2024

Heather Robles, PharmD and Talia Puzantian, PharmD, BCPP

Heather Robles, PharmD candidate, and Talia Puzantian, PharmD, BCPP. Ms. Robles and Dr. Puzantian have no financial relationships with companies related to this material.

A brief review of hyponatremia including medications that cause it, symptoms to look out for, and how to prevent and treat this common side effect.

News of Note

Brexpiprazole

October 31, 2023

Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP

Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease.

EXPERT Q&A

Buprenorphine and Dental Issues

January 30, 2023

Talia Puzantian, PharmD, BCPP

Talia Puzantian, PharmD, BCPP.

Deputy editor for The Carlat Addiction Treatment Report. Professor, Keck Graduate Institute School of Pharmacy. Claremont, CA.

Dr. Puzantian has no financial relationships with companies related to this material.

Buprenorphine is a first line treatment for opioid use disorder and has saved countless lives, but new warnings about associations between certain buprenorphine formulations and dental problems have people worried. Here, Dr. Puzantian reviews the data and shows us how to apply this new information to clinical care.

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test

January 20, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test

January 20, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023).

PDF Access and 10 CME Post-Test

January 20, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)

PDF/eBook Access with 12 CME Post-Test For A Spiral Bound Copy

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) and download links PDF/eBook access.